|
|
|
 |
|
|
 |
News and Press Releases |
 |
BioBLU® family grows
Juelich/Hannover, October 14th, 2013 – At this year’s BIOTECHNICA in Hannover, Germany Eppendorf has presented the newest members of its single-use bioreactor family BioBLU for the first time. With the new single-use bioreactor BioBLU 1c for cell culture and BioBLU 1f for microbial applications Eppendorf further extends its portfolio of rigid wall single-use bioreactors. These 1 L vessels are bridging the gap between the BioBLU 0.3 c/f mini single-use bioreactors and the larger vessels of the BioBLU family. Users in cell culture, who want to combine the advantages of single-use technology with the proven qualities of stirred-tank bioreactor design can now benefit from an unmatched portfolio of rigid wall stirred tank single-use bioreactors with working volumes from 100 mL – 40 L.
More info >> |
|
 |
White Papers |
 |
|
Soothing the Logistical Headache of Clinical Trials
Equilibrium Travel Management
As many as 30 per cent of subjects on phase three clinical studies drop out. Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial. It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >> |
|
 |
Industry Events |
 |
Advances and Progress in Drug Design
17-18 February 2014, Marriott Regents Park Hotel, London, UK
SMi are proud to present the 13th annual Advances and Progress in Drug
Design conference, convening in Central London on Monday 17 and Tuesday 18 February 2014. This exciting event will
focus on new approaches and will offer attendees the chance to hear from
leading industry experts on lead optimisation strategies, SBDD and FBDD.
More info >> |
|
|
